Skip to content
Immunexpress
  • Home
  • About Us
    • About Immunexpress
    • Executive Team
    • Board Of Directors
    • Careers
  • About Sepsis
    • The Sepsis Problem
    • Partnership with Sepsis Alliance
    • External Resources
  • About SeptiCyte®
    • SeptiCyte™ RAPID
    • Host Response
    • SeptiCyte™ LAB
  • Validation
    • Clinical Validation
    • Publications
    • Collaborators
  • Newsroom
  • Contact Us
Immunexpress
  • Home
  • About Us
    • About Immunexpress
    • Executive Team
    • Board Of Directors
    • Careers
  • About Sepsis
    • The Sepsis Problem
    • Partnership with Sepsis Alliance
    • External Resources
  • About SeptiCyte®
    • SeptiCyte™ RAPID
    • Host Response
    • SeptiCyte™ LAB
  • Validation
    • Clinical Validation
    • Publications
    • Collaborators
  • Newsroom
  • Contact Us

Archive for October 2020

Biocartis announces market release of SeptiCyte RAPID test on Idylla

By Josephine Galatioto | October 6, 2020

Biocartis Group has released of SeptiCyte RAPID on Idylla as a CE-marked IVD test. SeptiCyte RAPID is a host-response test that distinguishes sepsis from non-infectious systemic inflammation in patients suspected of sepsis and provides actionable results in about one hour.

Read More

Q&A: Sepsis detection technology that can triage COVID-19 patients

By Josephine Galatioto | October 2, 2020

Ian Bolland caught up with Dr. Rolland Carlson, CEO of Immunexpress, to talk about a molecular diagnostic, SeptiCyte RAPID, which is used to detect sepsis and offers the potential to triage severe COVID-19 patients in the emergency department. Expand Briefly, tell us more about Immunexpress – how did the idea to start the company come…

Read More

About Us

Immunexpress is a privately-owned group of companies developing and commercializing revolutionary molecular diagnostics to aid clinicians in managing patients with, or suspected of, sepsis through analysis of molecular blood biomarkers from a patient’s immune system (the ‘host response’).

Additional Resources

Newsroom


Contact Us


Privacy policy


 

Tweets by @Immunexpress

© 2023 Immunexpress Inc. — all Rights Reserved.
425 Pontius Avenue North, Suite 470, Seattle, WA 98109 USA
+1 206.858.6436 – info@immunexpress.com

Scroll To Top